- Home
- WY vs BNTX Comparison
WY vs BNTX Comparison
Compare WY & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WY
- BNTX
- Stock Information
- Founded
- WY 1900
- BNTX 2008
- Country
- WY United States
- BNTX Germany
- Employees
- WY N/A
- BNTX N/A
- Industry
- WY Real Estate Investment Trusts
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WY Real Estate
- BNTX Health Care
- Exchange
- WY Nasdaq
- BNTX Nasdaq
- Market Cap
- WY 22.5B
- BNTX 23.9B
- IPO Year
- WY N/A
- BNTX 2019
- Fundamental
- Price
- WY $30.04
- BNTX $120.38
- Analyst Decision
- WY Buy
- BNTX Strong Buy
- Analyst Count
- WY 6
- BNTX 15
- Target Price
- WY $36.33
- BNTX $143.50
- AVG Volume (30 Days)
- WY 3.1M
- BNTX 1.0M
- Earning Date
- WY 01-23-2025
- BNTX 11-04-2024
- Dividend Yield
- WY 2.67%
- BNTX N/A
- EPS Growth
- WY N/A
- BNTX N/A
- EPS
- WY 0.73
- BNTX N/A
- Revenue
- WY $7,190,000,000.00
- BNTX $3,390,698,192.00
- Revenue This Year
- WY N/A
- BNTX N/A
- Revenue Next Year
- WY $8.08
- BNTX N/A
- P/E Ratio
- WY $41.16
- BNTX N/A
- Revenue Growth
- WY N/A
- BNTX N/A
- 52 Week Low
- WY $26.73
- BNTX $76.53
- 52 Week High
- WY $36.27
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- WY 36.78
- BNTX 57.39
- Support Level
- WY $30.73
- BNTX $116.73
- Resistance Level
- WY $31.93
- BNTX $123.30
- Average True Range (ATR)
- WY 0.68
- BNTX 4.49
- MACD
- WY -0.13
- BNTX 0.45
- Stochastic Oscillator
- WY 8.59
- BNTX 59.65
About WY Weyerhaeuser Company
Weyerhaeuser ranks among the world's largest forest product companies. Following the 2016 sale of its pulp business to International Paper, Weyerhaeuser operates three business segments: timberlands, wood products, and real estate. Weyerhaeuser is structured as a real estate investment trust and is not required to pay federal income taxes on earnings generated by timber harvest activities. Earnings from its wood products segment are subject to federal income tax. Weyerhaeuser acquired fellow timber REIT Plum Creek in 2016.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.